BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15046109)

  • 21. Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
    Guarnieri V; Bisceglia M; Bonfitto N; Cetani F; Marcocci C; Minisola S; Battista C; Chiodini I; Cole DE; Scillitani A
    Surgery; 2008 Nov; 144(5):839-40. PubMed ID: 19081034
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
    Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
    Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2.
    Hobbs MR; Rosen IB; Jackson CE
    Am J Hum Genet; 2002 May; 70(5):1376-7. PubMed ID: 11951180
    [No Abstract]   [Full Text] [Related]  

  • 24. Parathyroid carcinoma.
    Mittendorf EA; McHenry CR
    J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
    Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
    Nat Genet; 2002 Dec; 32(4):676-80. PubMed ID: 12434154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
    Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
    Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation.
    Aldred MJ; Talacko AA; Savarirayan R; Murdolo V; Mills AE; Radden BG; Alimov A; Villablanca A; Larsson C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):212-8. PubMed ID: 16448924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.
    Yamashita Y; Akiyama T; Mizusawa N; Yoshimoto K; Goto M
    Int J Oral Maxillofac Surg; 2007 Apr; 36(4):365-9. PubMed ID: 17052894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
    Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
    Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
    Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
    Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the contribution of HRPT2 to the pathogenesis of jaw fibrous dysplasia, ossifying fibroma, and osteosarcoma.
    de Mesquita Netto AC; Gomez RS; Diniz MG; Fonseca-Silva T; Campos K; De Marco L; Carlos R; Gomes CC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):359-67. PubMed ID: 23453027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperparathyroidism-jaw tumor syndrome: a case report.
    Schmidt BP; Bradrick JP; Gabali A
    J Oral Maxillofac Surg; 2009 Feb; 67(2):423-7. PubMed ID: 19138622
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome.
    De Luise M; Iommarini L; Marchio L; Tedesco G; Coadă CA; Repaci A; Turchetti D; Tardio ML; Salfi N; Pagotto U; Kurelac I; Porcelli AM; Gasparre G
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.
    Bradley KJ; Hobbs MR; Buley ID; Carpten JD; Cavaco BM; Fares JE; Laidler P; Manek S; Robbins CM; Salti IS; Thompson NW; Jackson CE; Thakker RV
    J Intern Med; 2005 Jan; 257(1):18-26. PubMed ID: 15606373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome.
    Jackson CE; Norum RA; Boyd SB; Talpos GB; Wilson SD; Taggart RT; Mallette LE
    Surgery; 1990 Dec; 108(6):1006-12; discussion 1012-3. PubMed ID: 2123361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
    Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
    Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical assessment of parafibromin in mouse and human tissues.
    Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
    J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
    Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
    Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.